Skip to main content
Screener/Healthcare/Biotechnology

FOLD — Amicus Therapeutics, Inc.

NASDAQ
$14.49 (—)
Mid CapUnder $20HealthcareLow Beta
$5.51
$14.50
—
—
EPS (TTM)$-0.09
P/E Ratio-165.17
Dividend Yield—
Market Cap$4.55B
Volume—
Prev Close$14.46
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$185.2M$1.7M$0.0184.6%0.9%
Q3 '25$169.1M$17.3M$0.0687.4%10.2%
Q2 '25$154.7M-$24.4M$-0.0890.2%-15.8%
Q1 '25$125.2M-$21.7M$-0.0790.7%-17.3%
Q4 '24$149.7M$14.7M$0.0590.1%9.8%
Q3 '24$141.5M-$6.7M$-0.0290.6%-4.8%
Q2 '24$126.7M-$15.7M$-0.0591.1%-12.4%
Q1 '24$110.4M-$48.4M$-0.1687.7%-43.9%
Get Your Daily Market Recap